BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang J, Chen L, Qiang P. The role of IGF2BP2, an m6A reader gene, in human metabolic diseases and cancers. Cancer Cell Int 2021;21:99. [PMID: 33568150 DOI: 10.1186/s12935-021-01799-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhi S, Li J, Kong X, Xie X, Zhang Q, Fang G. Insulin-like growth factor 2 mRNA binding protein 2 regulates proliferation, migration, and angiogenesis of keratinocytes by modulating heparanase stability. Bioengineered 2021;12:11267-76. [PMID: 34753397 DOI: 10.1080/21655979.2021.2002495] [Reference Citation Analysis]
2 Wang Y, Li L, Li J, Zhao B, Huang G, Li X, Xie Z, Zhou Z. The Emerging Role of m6A Modification in Regulating the Immune System and Autoimmune Diseases. Front Cell Dev Biol 2021;9:755691. [PMID: 34869344 DOI: 10.3389/fcell.2021.755691] [Reference Citation Analysis]
3 Tan L, Tang Y, Li H, Li P, Ye Y, Cen J, Gui C, Luo J, Cao J, Wei J. N6-Methyladenosine Modification of LncRNA DUXAP9 Promotes Renal Cancer Cells Proliferation and Motility by Activating the PI3K/AKT Signaling Pathway. Front Oncol 2021;11:641833. [PMID: 34168980 DOI: 10.3389/fonc.2021.641833] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Cong P, Wu T, Huang X, Liang H, Gao X, Tian L, Li W, Chen A, Wan H, He M, Dai D, Li Z, Xiong L. Identification of the Role and Clinical Prognostic Value of Target Genes of m6A RNA Methylation Regulators in Glioma. Front Cell Dev Biol 2021;9:709022. [PMID: 34589481 DOI: 10.3389/fcell.2021.709022] [Reference Citation Analysis]
5 Zhang Z, Xing Y, Gao W, Yang L, Shi J, Song W, Li T. N6-methyladenosine (m6A) reader IGF2BP2 promotes gastric cancer progression via targeting SIRT1. Bioengineered 2022;13:11541-50. [PMID: 35502827 DOI: 10.1080/21655979.2022.2068920] [Reference Citation Analysis]
6 Sa R, Liang R, Qiu X, He Z, Liu Z, Chen L. IGF2BP2-dependent activation of ERBB2 signaling contributes to acquired resistance to tyrosine kinase inhibitor in differentiation therapy of radioiodine-refractory papillary thyroid cancer. Cancer Lett 2021;527:10-23. [PMID: 34896211 DOI: 10.1016/j.canlet.2021.12.005] [Reference Citation Analysis]
7 Li M, Rong X, Lu L, Li Y, Yao K, Ge W, Duan C. IGF-2 mRNA binding protein 2 regulates primordial germ cell development in zebrafish. Gen Comp Endocrinol 2021;313:113875. [PMID: 34352271 DOI: 10.1016/j.ygcen.2021.113875] [Reference Citation Analysis]
8 Korn SM, Ulshöfer CJ, Schneider T, Schlundt A. Structures and target RNA preferences of the RNA-binding protein family of IGF2BPs: An overview. Structure 2021;29:787-803. [PMID: 34022128 DOI: 10.1016/j.str.2021.05.001] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Dong L, Geng Z, Liu Z, Tao M, Pan M, Lu X. IGF2BP2 knockdown suppresses thyroid cancer progression by reducing the expression of long non-coding RNA HAGLR. Pathol Res Pract 2021;225:153550. [PMID: 34340128 DOI: 10.1016/j.prp.2021.153550] [Reference Citation Analysis]
10 Zhang L, Xia J. N6-Methyladenosine Methylation of mRNA in Cell Senescence. Cell Mol Neurobiol 2021. [PMID: 34767142 DOI: 10.1007/s10571-021-01168-2] [Reference Citation Analysis]
11 Chen HM, Lin CC, Chen WS, Jiang JK, Yang SH, Chang SC, Ho CL, Yang CC, Huang SC, Chao Y, Liao TT, Hwang WL, Teng HW. Insulin-Like Growth Factor 2 mRNA-Binding Protein 1 (IGF2BP1) Is a Prognostic Biomarker and Associated with Chemotherapy Responsiveness in Colorectal Cancer. Int J Mol Sci 2021;22:6940. [PMID: 34203267 DOI: 10.3390/ijms22136940] [Reference Citation Analysis]
12 Du QY, Zhu ZM, Pei DS. The biological function of IGF2BPs and their role in tumorigenesis. Invest New Drugs 2021. [PMID: 34251559 DOI: 10.1007/s10637-021-01148-9] [Reference Citation Analysis]
13 Yu D, Pan M, Li Y, Lu T, Wang Z, Liu C, Hu G. RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner. J Exp Clin Cancer Res 2022;41:6. [PMID: 34980207 DOI: 10.1186/s13046-021-02212-1] [Reference Citation Analysis]
14 Miao C, Fang X, Chen Y, Zhao Y, Guo Q. Identification of an eight-m6A RNA methylation regulator prognostic signature of uterine corpus endometrial carcinoma based on bioinformatics analysis. Medicine (Baltimore) 2021;100:e27689. [PMID: 34889221 DOI: 10.1097/MD.0000000000027689] [Reference Citation Analysis]